Part of GSK Plc, GlaxoSmithKline Intellectual Property Development Ltd. is a British company located in Middlesex that functions as an investment holding company. It was founded in 2012.\nThe company says this about itself: The Company is a member of the GlaxoSmithKline Group (the \"Group\"). The Company's principal activities are the development, enhancement, maintenance, protection and exploitation of intellectual property assets owned by the Company which may include but are not limited to, licensing out intellectual property rights relating to pharmaceutical products to the GlaxoSmithKline Group of companies (the \"Group\") and carrying out research and development activities.

Cancer Research Ventures Ltd. engages in the business of research and experimental development on biotechnology. It provides medical products. The company is headquartered in London, the United Kingdom.

SuperGen, Inc., a pharmaceutical company, engages in the discovery, development, and commercialization of therapies to treat patients with cancer. Products in Development MP-470—DNA Repair Suppressor: MP-470 is a multi-targeted Tyrosine Kinase Inhibitor that is specific for mutant forms of c-kit, PDGFRa, and FLT3. These protein kinase targets are involved in the growth and proliferation of cancer cells. MP-470 is also a suppressor of Rad51, a DNA repair protein which is involved in resistance to various chemotherapy agents and radiation. SuperGen, Inc. was founded in 1991.

Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts is a teaching hospital of Harvard Medical School. It was formed out of the 1996 merger of Beth Israel Hospital (founded in 1916) and New England Deaconess Hospital (founded in 1896). Among independent teaching hospitals, Beth Israel Deaconess Medical Center consistently ranks in the top three recipients of biomedical research funding from the National Institutes of Health. Research funding totals nearly $200 million annually. BIDMC researchers run more than 850 active sponsored projects and 200 clinical trials. The Harvard-Thorndike General Clinical Research Center, the oldest clinical research laboratory in the United States, has been located on this site since 1973.

Consiglio Nazionale delle Ricerche is the largest public research facility in Italy. Founded in 1923, it has worked in the past as a government consultant on research and as a funding fund for university research grants. Since 1989 the CNR is a research institution, with the mission of carrying out research projects, promoting innovation and competitiveness of the national industrial system, the internationalization of the national research system, and providing technologies and solutions to emerging needs in the public and private sectors. . Objectives that are achieved through a wealth of human resources that has over 8000 employees, half of which is represented by researchers and technologists. About 4,000 young researchers are involved in post-doctoral research activities in the laboratories of the Institute, while an important contribution comes from collaborations, including international ones, with researchers from universities and companies, thus strengthening the national research system.

Regents of The University of Michigan provides administers bonds on behalf of the University. The company is headquartered in Ann Arbor, MI.

Zhejiang Gaomei Biotechnology Co., Ltd., established on 2019-03-26, The scope of business includes biological genes,medical test,Technology research and development of biomedicine,technical consulting,Technical Services,technology transfer;Research and development of clinical diagnostic reagents and instruments,Sales;Development of bioinformatics software,Sales and technical service;Laboratory equipment and consumables sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Hunan Keyu Biomedical Technology Co., Ltd., established on 2015-05-25, Business scope includes biological products,medicine,Class II:6840In vitro diagnostic reagents,Research and development of network technology;Chemical Reagents and Auxiliaries(Monitor Chemicals,Excluding hazardous chemicals),Medical Laboratory Equipment and Appliances,Sales of laboratory equipment and ventilation systems;Advertising Design;Advertising production service,publish service,Domestic agency service;basic software,Support software,Application software development;Biotechnology Extension Services;medical information,Technical Advisory Services;Medical Research and Experimental Development;Conference Services;Development and construction of computer network platform.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and medical devices. Its products include cardiovascular drugs and medical devices; cephalosporin antibiotics and raw materials; and bone resorption inhibitor drugs. The company was founded on November 3, 1998 and is headquartered in Shenzhen, China.

Part of Shenzhen Salubris Pharmaceuticals Co., Ltd., Genekey Biotech (Chengdu) Co. Ltd. is a Chinese company located in Chengdu that engages in researching and developing chemical products. Shenzhen Salubris Pharmaceuticals Co., Ltd. acquired Genekey Biotech (Chengdu) Co. Ltd. from Salubris (Suzhou) Pharmaceuticals Co., Ltd. on December 27, 2014 for $7.53 million.

Shenzhen Nuclear Gene Technology Co., Ltd., established on 2012-04-27, Business scope includes general business items:Technical development of genetic testing products,Health Information Consultation(Excluding medical behavior and restricted items) ;Gene-related technology development;Biological product technology development;Operating import and export business;Domestic Trade.(Laws of the above items,Administrative regulations,Except for those prohibited by the decision of the State Council,Restricted projects must obtain a license before operating),The licensing program is:Sales of Class II Medical Devices,Sales of Class III Medical Devices.